Reinier de Graaf Groep

2 in Phase 3

Quick facts

Phase 3 pipeline

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about Reinier de Graaf Groep

What is Reinier de Graaf Groep's pipeline?

Reinier de Graaf Groep has 2 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include spinal administration of articaine, spinal administration of bupivacaine.

Related